Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

Almost half of all FDA warnings letters since early 2018 were sent to Indian and Chinese plants, according to a report. (FDA) China and India, which are the largest producers of APIs for the U.S. drug ...

In drug development, the active pharmaceutical ingredient (API) is the drug component that provides the health benefits. The purpose of adding APIs is to cause pharmacological activity or direct ...

CDMO giant Lonza has been on an expansion tear in recent years, announcing in August 2021 the addition of a fill-finish line at its Guangzhou, China, facility and in May that it would shell out $935 ...

The Active Pharmaceutical Ingredients (API) Market plays a crucial role in the pharmaceutical industry, forming the backbone of drug development and production. APIs are the biologically active ...

Health experts and pharmaceutical industry leaders yesterday called for policy support and the removal of tariff and non-tariff barriers to boost local production of raw materials for drugs, aiming to ...

External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ...

Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...